Results show that expression trends in TCR-Co (αCD3+αCD28) stimulated healthy Tregs under IL-2 withdrawal were in agreement with expression trends in Tregs from T1D subjects, for 19 of the 32 assayed genes (Figure 5). This evidence concerns the gene IL2 and type 1 diabetes mellitus.